Home›Companies›Biotech & Pharma›Aspire BioPharma

Aspire BioPharma, Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 1, 2023·Suggest an edit

About Aspire BioPharma

Aspire BioPharma is a private company based in Humacao, Puerto Rico, incorporated in 2021 in Puerto Rico. It has reported $0 raised in one offering on Form D since November 2023. Its chief executive is Kraig Higginson.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetNov 1, 2023$0of $10.0M target0—EquityRule 506(c)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Aspire BioPharma's Form D filed Nov 1, 2023.

ES
Ernest Scheidemann
Executive officer and director
RP
Rodrick Prat
Director
KH
Kraig Higginson
President and CEO, director
SQ
Stephen Quesenberry
Executive officer and director
EK

Sources

  1. SECAspire BioPharma, Inc. filing history